TC BioPharm (Holdings) plc ADR (TCBP)’s stock is trading at $1.56 at the moment marking a rise of 42.04% from the last session close. As of this writing, shares are priced at -98.99% less than their 52-week high of $155.40, and 83.79% over their 52-week low of $0.85. Based on the past 30-day period, the stock price is -44.62% below the high and +87.62% above the low.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, TCBP’s SMA-200 is $9.3925.

Further, it is important to consider TCBP stock ratios, particularly its price-to-sales ratio over the past twelve months, which stands at 0.32.TCBP’s price to book ratio for the most recent quarter was 121.87, resulting in an 0.44 price to cash per share for the period.

How does TC BioPharm (Holdings) plc ADR (TCBP) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.

TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP) Ownership Details

I will give a breakdown of the key shareholders in TC BioPharm (Holdings) plc ADR (TCBP). Recent figures show that the company’s insiders hold 0.14% of shares. A total of 12 institutional investors hold shares in the company, making 0.29% of its stock and 0.29% of its float.

Sep 29, 2023, it was reported that the Company’s largest institutional holder is Armistice Capital, LLC holding total of 29750.0 shares that make 4.40% of the company’s total number of shares and are currently priced at 41950.0.

The securities firm Csenge Advisory Group holds 2600.0 shares of TCBP, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.38%, and the holding percentage of shares is valued at 3666.0.

An overview of TC BioPharm (Holdings) plc ADR’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests TC BioPharm (Holdings) plc ADR (TCBP) traded 1,332,307 shares per day, with a moving average of $1.6056 and price change of -0.8550. With the moving average of $3.0042 and a price change of -6.1650, about 632,219 shares changed hands on average over the past 50 days. Finally, TCBP’s 100-day average volume is 335,516 shares, alongside a moving average of $5.7024 and a price change of -7.9030.

Leave a Reply

Your email address will not be published. Required fields are marked *